Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Use of Longfengbao capsule in preparing medicine for preventing and treating cerebral arteriosclerosis and related diseases thereof

A technology of cerebral arteriosclerosis and Longfengbao, which is applied in the field of medicine, can solve the problems of undisclosed Longfengbao capsules such as cerebral arteriosclerosis, and achieve the effects of reducing cerebrovascular resistance, lowering blood pressure and memory, and increasing cerebral blood flow

Inactive Publication Date: 2021-07-16
GUANGZHOU BAIYUNSHAN QIXING PHARMA
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Longfengbao Capsule is a Chinese patent medicine exclusively produced by Guangzhou Baiyunshan Qixing Pharmaceutical Co., Ltd. The prescription is composed of herbal medicines such as Epimedium, Cistanche, Astragalus, and Codonopsis. It has been disclosed in literature that Longfengbao Capsule can treat menopausal syndrome, neurasthenia, etc. It does not disclose that Longfengbao Capsule has the effect of treating cerebral arteriosclerosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of Longfengbao capsule in preparing medicine for preventing and treating cerebral arteriosclerosis and related diseases thereof
  • Use of Longfengbao capsule in preparing medicine for preventing and treating cerebral arteriosclerosis and related diseases thereof
  • Use of Longfengbao capsule in preparing medicine for preventing and treating cerebral arteriosclerosis and related diseases thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Example 1 Validation of Longfengbao Capsules in the Treatment of Cerebral Arteriosclerosis

[0024] 1. Effect of Longfengbao Capsules on cerebral blood flow in dogs

[0025] Select healthy dogs, both male and female, and use pentobarbital intravenous anesthesia, dissect left and right carotid arteries, ligate external carotid artery and occipital artery, keep only internal carotid artery to enter the brain, and insert femoral vein cannula at the same time for drug administration and fluid replacement Intravenously inject 750 units / kg of heparin, use a self-made plastic cannula with both ends of the cannula to collect proximal arterial blood, connect to the bubble flow meter, and then flow back to the distal artery and enter the cerebral circulation. A tube was introduced at the cannula for blood pressure measurement, and a three-way switch was installed at the distal end for drug use, and the cerebral blood flow was measured and recorded for 10 minutes. At the end of t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to use of a Longfengbao capsule in preparing a medicine for preventing and treating cerebral arteriosclerosis and related diseases thereof. Animal experiments prove that the Longfengbao capsule has very good effects of increasing cerebrovascular flow, reducing cerebral blood resistance, reducing heart rate and reducing cerebral blood pressure. Clinical test results prove that the Longfengbao capsule has good relieving effects on headache, dizziness, lassitude, fatigue and insomnia of patients with cerebral arteriosclerosis, and also has effects of reducing blood fat, reducing blood pressure and improving memory.

Description

technical field [0001] The invention relates to the field of medicine, in particular to the application of Longfengbao Capsules in the preparation of medicines for preventing and treating cerebral arteriosclerosis and related diseases. Background technique [0002] Cerebral arteriosclerosis refers to chronic encephalopathy such as neurasthenia syndrome, arteriosclerotic dementia, and pseudobulbar palsy caused by multiple cerebral infarctions, softening, necrosis, and atrophy after cerebral arteriosclerosis. Cerebral arteriosclerosis can cause acute cerebral circulation disorders such as transient ischemic attack (TIA) and stroke, as well as chronic cerebral ischemic symptoms. The disease is more common in people over the age of 50. With the aging process of the world's population and the improvement of people's living standards, its harmfulness is increasing year by year. [0003] Longfengbao Capsule is a Chinese patent medicine exclusively produced by Guangzhou Baiyunshan...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8969A61K9/48A61P9/10A61P9/12A61P3/06A61P25/28A61P39/00A61P25/20A61P1/08A61P25/00A61K31/045
CPCA61K9/48A61K31/045A61K36/296A61K36/344A61K36/481A61K36/64A61K36/65A61K36/71A61K36/714A61K36/734A61K36/8969A61P1/08A61P3/06A61P9/10A61P9/12A61P25/00A61P25/20A61P25/28A61P39/00A61K2300/00
Inventor 张春波苏碧茹伏宝香彭中芳锶景希
Owner GUANGZHOU BAIYUNSHAN QIXING PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com